220 related articles for article (PubMed ID: 29426226)
1. Shape of Nanoparticles as a Design Parameter to Improve Docetaxel Antitumor Efficacy.
Guo Y; Zhao S; Qiu H; Wang T; Zhao Y; Han M; Dong Z; Wang X
Bioconjug Chem; 2018 Apr; 29(4):1302-1311. PubMed ID: 29426226
[TBL] [Abstract][Full Text] [Related]
2. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
3. Influence of Hydrophobic Chains in Nanocarriers on Antitumor Efficacy of Docetaxel Nanoparticles.
Dong Z; Shen Y; Zhao S; Wang X; Han M; Zhao N; Ao H; Guo Y
Mol Pharm; 2020 Apr; 17(4):1205-1214. PubMed ID: 32073273
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
5. Functionalized docetaxel-loaded lipid-based-nanosuspensions to enhance antitumor efficacy in vivo.
Pang X; Wang T; Jiang D; Mu W; Zhang B; Zhang N
Int J Nanomedicine; 2019; 14():2543-2555. PubMed ID: 31114190
[No Abstract] [Full Text] [Related]
6. Drug-interactive mPEG-
Gong F; Wang R; Zhu Z; Duan J; Teng X; Cui ZK
Drug Deliv; 2020 Dec; 27(1):238-247. PubMed ID: 32003299
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of raloxifene-targeted poly(styrene maleic acid)-poly (amide-ether-ester-imide) co-polymeric nanomicelles loaded with docetaxel in breast cancer-bearing mice.
Enteshari S; Varshosaz J; Minayian M; Hassanzadeh F
Invest New Drugs; 2018 Apr; 36(2):206-216. PubMed ID: 29177974
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel loaded mPEG-PLA nanoparticles for sarcoma therapy: preparation, characterization, pharmacokinetics, and anti-tumor efficacy.
Chen J; Ning E; Wang Z; Jing Z; Wei G; Wang X; Ma P
Drug Deliv; 2021 Dec; 28(1):1389-1396. PubMed ID: 34180752
[TBL] [Abstract][Full Text] [Related]
10. Development of self-assembled nanocarriers to enhance antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell line.
Rarokar NR; Khedekar PB; Bharne AP; Umekar MJ
Int J Biol Macromol; 2019 Mar; 125():1056-1068. PubMed ID: 30572051
[TBL] [Abstract][Full Text] [Related]
11. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells.
da Rocha MCO; da Silva PB; Radicchi MA; Andrade BYG; de Oliveira JV; Venus T; Merker C; Estrela-Lopis I; Longo JPF; Báo SN
J Nanobiotechnology; 2020 Mar; 18(1):43. PubMed ID: 32164731
[TBL] [Abstract][Full Text] [Related]
13. Development of synthetic high-density lipoprotein-based ApoA-I mimetic peptide-loaded docetaxel as a drug delivery nanocarrier for breast cancer chemotherapy.
Gong M; Zhang Q; Zhao Q; Zheng J; Li Y; Wang S; Yuan Y
Drug Deliv; 2019 Dec; 26(1):708-716. PubMed ID: 31290708
[TBL] [Abstract][Full Text] [Related]
14. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
15. Co-encapsulation of docetaxel and cyclosporin A into SNEDDS to promote oral cancer chemotherapy.
Cui W; Zhao H; Wang C; Chen Y; Luo C; Zhang S; Sun B; He Z
Drug Deliv; 2019 Dec; 26(1):542-550. PubMed ID: 31090467
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo.
Zhao Y; Guo Y; Li R; Wang T; Han M; Zhu C; Wang X
Sci Rep; 2016 Jul; 6():28983. PubMed ID: 27388443
[TBL] [Abstract][Full Text] [Related]
17. Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells.
Kim CH; Kang TH; Kim BD; Lee TH; Yoon HY; Goo YT; Choi YS; Kang MJ; Choi YW
Int J Pharm; 2020 Jun; 583():119393. PubMed ID: 32376445
[TBL] [Abstract][Full Text] [Related]
18. Hydroxycamptothecin nanoparticles based on poly/oligo (ethylene glycol): Architecture effects of nanocarriers on antitumor efficacy.
Guo Y; Wang T; Qiu H; Han M; Dong Z; Wang X; Wang Y
Eur J Pharm Biopharm; 2019 Jan; 134():178-184. PubMed ID: 30529294
[TBL] [Abstract][Full Text] [Related]
19. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
Jiang S; Gong X; Zhao X; Zu Y
Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
